The volume of production of pharmaceutical products in Russia in January-October 2012 increased by 20% compared to the same period last year, according to the operative report of Rosstat.
In October, production increased compared to October of last year by 12.4%, as compared to September this year — by 2.1%. In particular, the production of antibiotics, put up in packaging, in October 2012 increased by 2.6% year on year and amounted to 11.9 million packages in bottles — decreased by 6.9% to 37.1 million units. Drugs for the treatment of cardiovascular diseases in the packaging for the same period were produced by 5.7% less than in October last year — 32.7 million packages of similar drugs in capsules — a 0.6% increase, 21.8 million shares.
The manufacture of drugs to treat cancer in packages — twice, to 1.07 million packs, but in the form of bottles — decreased by 39.3% to 82 thousand bottles.
Production of painkillers, antipyretics and anti-inflammatory drugs in packages in October decreased by 4.1% — to 75.1 million units, production of ampoules with similar drugs — by 10.4%, to 33.1 million units.
Manufacture of other plasma substitutes and resources in packages decreased by 11.6% — up to 3.6 million shares, in the form of ampoules — by 36.7% to 1.73 million units.
Production of anti-TB drugs in packages decreased by 47.8% to 616,000 packages in capsules — was 179,000 pieces. The volume of production of drugs for the treatment of dysbiosis increased by 2.9% — to 42.2 million doses.
Release of drugs for the treatment of diabetes mellitus in packages of up to 63% — up to 802 thousand units in vials — 2.9-fold, to 55,000 units. Drugs for the treatment of eye diseases in October were produced 5.8 million units, which is 14% higher than October of the previous year.
Release of drugs for the treatment of diseases of the digestive and endocrine system decreased by 9.4% in units — up to 39 million units in ampoules — by 6.1%, to 8.4 million vials. Production of drugs for the treatment of neuropsychiatric diseases in October in packages increased by 13.5% — to 10.7 million units in ampoules — by 61.3%, to 9.2 million units.
The volume of production of drugs for anesthesia and local anesthesia in packages dropped by 45.5% — up to 289 thousand units, and similar drugs in capsules — by 38.9%, to 6.9 million vials. The volume of production of drugs used in obstetric practice, fell in October by 19.4% to 1.8 million packages in capsules — increased by 2.6 times, to 2.5 million units.
Release of anti-asthmatic and anti-histamines off in October in packages of 25.4% to 3,000,000 units, in ampoules — by 2%, to 1.5 million.
Production of vitamins in containers decreased by 2.4% — to 23.9 million units, and in capsules — by 28.5%, to 13.5 million units.